Skip to main content
Springer logoLink to Springer
. 2023 May 9;102(7):1969. doi: 10.1007/s00277-023-05242-1

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response

Amanda Pifano Soares Ferreira 1,2, Fernanda Salles Seguro 2,3, Andre Ramires Neder Abdo 3, Fernanda Maria Santos 3, Felipe Vieira Rodrigues Maciel 3,6, Luciana Nardinelli 4, Ricardo Rodrigues Giorgi 4, Antonio Roberto Lancha Ruiz 2, Milton Pifano Soares Ferreira 5, Eduardo Magalhaes Rego 2,3,4, Vanderson Rocha 2,3,4, Israel Bendit 2,4,6,
PMCID: PMC10260693  PMID: 37160499

Correction to: Annals of Hematology

10.1007/s00277-023-05189-3

In the published paper, almost all the figures and tables of the article (Table 1, table 2, figure 3, figure 4, figure 5 and figure 6 are incompatible with its current captions.

The original article has been corrected.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Annals of Hematology are provided here courtesy of Springer

RESOURCES